138 related articles for article (PubMed ID: 10448603)
21. Cytogenetics in multiple myeloma: a multicenter study of 24 patients with t(11;14)(q13;q32) or its variant.
Laï JL; Michaux L; Dastugue N; Vasseur F; Daudignon A; Facon T; Bauters F; Zandecki M
Cancer Genet Cytogenet; 1998 Jul; 104(2):133-8. PubMed ID: 9666807
[TBL] [Abstract][Full Text] [Related]
22. Karyotypic abnormalities and their clinical aspects in multiple myeloma.
Scudla V; Jarosová M; Kapustová M; Indrák K; Smoldas J
Acta Univ Palacki Olomuc Fac Med; 1991; 129():69-79. PubMed ID: 1837676
[TBL] [Abstract][Full Text] [Related]
23. Multiple myeloma and the translocation t(11;14)(q13;q32): a report on 13 cases.
Fonseca R; Witzig TE; Gertz MA; Kyle RA; Hoyer JD; Jalal SM; Greipp PR
Br J Haematol; 1998 May; 101(2):296-301. PubMed ID: 9609525
[TBL] [Abstract][Full Text] [Related]
24. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
[TBL] [Abstract][Full Text] [Related]
25. Cytogenetics of multiple myeloma: interpretation of fluorescence in situ hybridization results.
Harrison CJ; Mazzullo H; Cheung KL; Gerrard G; Jalali GR; Mehta A; Osier DG; Orchard KH
Br J Haematol; 2003 Mar; 120(6):944-52. PubMed ID: 12648063
[TBL] [Abstract][Full Text] [Related]
26. Establishment of a new human myeloma cell line, KMS-18, having t(4;14)(p16.3;q32.3) derived from a case phenotypically transformed from Ig A-lambda to BJP-lambda, and associated with hyperammonemia.
Otsuki T; Nakazawa N; Taniwaki M; Yamada O; Sakaguchi H; Wada H; Yawata Y; Ueki A
Int J Oncol; 1998 Mar; 12(3):545-52. PubMed ID: 9472091
[TBL] [Abstract][Full Text] [Related]
27. [Comparative study of genetic aberrations in human multiple myeloma cell lines and newly diagnosed MM by fluorescence in situ hybridization].
An G; Xie ZQ; Li CH; Li Q; Yi SH; Qiu LG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1505-10. PubMed ID: 21176360
[TBL] [Abstract][Full Text] [Related]
28. Specific chromosomal aberrations in de novo acute myeloid leukemia: a comparative analysis of results with a report of three novel chromosomal rearrangements t(7;14)(q35;q13), t(8;18)(p11.2;q12), t(13;15) in Indian population.
Ahmad F; Dalvi R; Das BR; Mandava S
Cancer Detect Prev; 2008; 32(2):168-77. PubMed ID: 18639991
[TBL] [Abstract][Full Text] [Related]
29. [Multiple myeloma developing myelodysplastic syndrome with thrombocytosis].
Nakayama M; Kobayashi Y; Oshima Y; Uemura N; Shindo E; Tajika K; Yanagisawa K; Takahashi S; Irie S; Tojo A
Rinsho Ketsueki; 1995 Jul; 36(7):703-6. PubMed ID: 7563601
[TBL] [Abstract][Full Text] [Related]
30. Genomic aberrations in anaplastic multiple myeloma: high frequency of 1q21(CKS1B) amplifications.
Bahmanyar M; Qi X; Chang H
Leuk Res; 2013 Dec; 37(12):1726-8. PubMed ID: 24169086
[TBL] [Abstract][Full Text] [Related]
31. Burkitt translocation (8;22)(q24;q11) in a patient with multiple myeloma.
Look RM; Lim SW; Schreck RR; Lee S; Fuerst MP; Lawrence GN; Kusuanco DA; Kessler CE; Giles FJ
Cancer Genet Cytogenet; 1995 Jul; 82(2):100-2. PubMed ID: 7664237
[TBL] [Abstract][Full Text] [Related]
32. Correlation between losses of IGH or its segments and deletions of 13q14 in t(11;14) (q13;q32) multiple myeloma.
Trakhtenbrot L; Hardan I; Koren-Michowitz M; Oren S; Yshoev G; Rechavi G; Nagler A; Amariglio N
Genes Chromosomes Cancer; 2010 Jan; 49(1):17-27. PubMed ID: 19787791
[TBL] [Abstract][Full Text] [Related]
33. Nonrandom karyotype abnormalities in 36 multiple myeloma patients.
Ankathil R; Madhavan J; Gangadharan VP; Pillai GR; Nair MK
Cancer Genet Cytogenet; 1995 Aug; 83(1):71-4. PubMed ID: 7656209
[TBL] [Abstract][Full Text] [Related]
34. Recurrent involvement of heterochromatic regions in multiple myeloma-a multicolor FISH study.
Lange K; Gadzicki D; Schlegelberger B; Göhring G
Leuk Res; 2010 Aug; 34(8):1002-6. PubMed ID: 20022374
[TBL] [Abstract][Full Text] [Related]
35. Multicolour spectral karyotyping identifies new translocations and a recurring pathway for chromosome loss in multiple myeloma.
Sawyer JR; Lukacs JL; Thomas EL; Swanson CM; Goosen LS; Sammartino G; Gilliland JC; Munshi NC; Tricot G; Shaughnessy JD; Barlogie B
Br J Haematol; 2001 Jan; 112(1):167-74. PubMed ID: 11167798
[TBL] [Abstract][Full Text] [Related]
36. [Chromosome findings in multiple myeloma].
Suzuki K
Nihon Rinsho; 1995 Mar; 53(3):568-73. PubMed ID: 7699887
[TBL] [Abstract][Full Text] [Related]
37. Cytogenetic findings in 200 patients with multiple myeloma.
Sawyer JR; Waldron JA; Jagannath S; Barlogie B
Cancer Genet Cytogenet; 1995 Jul; 82(1):41-9. PubMed ID: 7627933
[TBL] [Abstract][Full Text] [Related]
38. Expression of fibroblast growth factor and FGF-receptor family genes in human myeloma cells, including lines possessing t(4;14)(q16.3;q32. 3) and FGFR3 translocation.
Otsuki T; Yamada O; Yata K; Sakaguchi H; Kurebayashi J; Nakazawa N; Taniwaki M; Yawata Y; Ueki A
Int J Oncol; 1999 Dec; 15(6):1205-12. PubMed ID: 10568829
[TBL] [Abstract][Full Text] [Related]
39. [Cytogenetic study of multiple myeloma].
Zhang Y; Jiang B; Huang XJ; Shi Y; He Q; Dang H; Qiu JY; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):76-8. PubMed ID: 17490526
[TBL] [Abstract][Full Text] [Related]
40. [Chromosome anomalies in Venezuelan patients with multiple myeloma].
Quintero M; Rojas-Atencio A; Ruiz A; González M; Herrera J; Atencio F; Delgado W; Urdaneta K; Pérez F
Invest Clin; 2003 Dec; 44(4):327-35. PubMed ID: 14727386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
